Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Melania Elena Pop-Tudose, Petru Armean & Ioan Victor Pop. (2022) Prenatal screening for Down syndrome: popularity, perceptions and factors associated with acceptance or refusal of testing. The Journal of Maternal-Fetal & Neonatal Medicine 35:25, pages 6505-6509.
Read now
Read now
Marcin Wiechec, Anna Knafel, Agnieszka Nocun, Artur Ludwin, Inga Ludwin, Marek Maczka, Damian Zietek, Marcin Pasternok, Dietmar Moosburger, Sebastian Zalewski & Wioletta Rozmus-Warcholinska. (2017) Screening for trisomy 18 using traditional combined screening vs. ultrasound-based protocol in tertiary center environment. The Journal of Maternal-Fetal & Neonatal Medicine 30:15, pages 1765-1770.
Read now
Read now
Dong-Zhi Li, Li Zhen, Min Pan, Jin Han, Xin Yang & Yan-Mei Ou. (2016) Non-invasive prenatal testing: impact on invasive prenatal diagnosis at a mainland Chinese tertiary medical center. The Journal of Maternal-Fetal & Neonatal Medicine 29:21, pages 3539-3541.
Read now
Read now
Articles from other publishers (11)
Han Kang, Lingxi Wang, Xingyu Li, Chonglan Gao, Yamei Xie & Yu Hu. (2022) Application of chromosome microarray analysis and karyotyping in diagnostic assessment of abnormal Down syndrome screening results. BMC Pregnancy and Childbirth 22:1.
Crossref
Crossref
Savas Ozdemir, Orhan Sahin, Zuat Acar, Gozde Zeynep Demir, Ece Ermin & Alev Aydin. (2022) Prediction of Pregnancy Complications With Maternal Biochemical Markers Used in Down Syndrome Screening. Cureus.
Crossref
Crossref
Clare Fiala, Jennifer Taher & Eleftherios P Diamandis. (2019) P4 Medicine or O4 Medicine? Hippocrates Provides the Answer. The Journal of Applied Laboratory Medicine 4:1, pages 108-119.
Crossref
Crossref
Enrico Carmina, Frank Z. Stanczyk & Rogerio A. Lobo. 2019. Yen and Jaffe's Reproductive Endocrinology. Yen and Jaffe's Reproductive Endocrinology
887
915.e4
.
Yuan Zhou, Yan Du, Bin Zhang & Ling Wang. (2018) Integrating multiple of the median values of serological markers with the risk cut-off value in Down syndrome screening. BioScience Trends 12:6, pages 613-619.
Crossref
Crossref
Melania Elena Pop-Tudose, Dana Popescu-Spineni, Petru Armean & Ioan Victor Pop. (2018) Attitude, knowledge and informed choice towards prenatal screening for Down Syndrome: a cross-sectional study. BMC Pregnancy and Childbirth 18:1.
Crossref
Crossref
Hui Xu, Jingyin Zhang, Yueshuang Xu, Huan Wang, Fanfan Fu, Qionghua Xu & Yunlang Cai. (2018) Down’s syndrome screening with hydrogel photonic barcodes. Sensors and Actuators B: Chemical 255, pages 2690-2696.
Crossref
Crossref
Peter O'Leary, Susannah Maxwell, Michael Sinosich, Kerry DeVoss, Janice Fletcher, Enzo Ranieri & Michael P. Metz. (2015) Screening for Down syndrome in the second trimester of pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 56:1, pages 19-21.
Crossref
Crossref
Marcin Wiechec, Anna Knafel, Agnieszka Nocun, Anna Matyszkiewicz, Magdalena Juszczak, Ewa Wiercinska & Emilia Latała. (2016) How Effective Is First-Trimester Screening for Trisomy 21 Based on Ultrasound Only?. Fetal Diagnosis and Therapy 39:2, pages 105-112.
Crossref
Crossref
J. Han, L. Zhen, M. Pan, X. Yang, Y.-M. Ou, C. Liao & D.-Z. Li. (2015) Uptake of non-invasive prenatal testing in Chinese women: money matters. European Journal of Obstetrics & Gynecology and Reproductive Biology 195, pages 100-102.
Crossref
Crossref
Seema Kapoor, Sangeeta Gupta & Madhulika Kabra. (2015) Prenatal screening: Perspective for the pediatrician. Indian Pediatrics 51:12, pages 959-962.
Crossref
Crossref